GL1X · GenesisL1 explorer

MolNFT v1 · #76316 · protein

Crystal structure of itk inhibitor complex

3QGY · Tyrosine-protein kinase ITK/TSK: “Crystal structure of itk inhibitor complex”. X-ray diffraction, 2 ligands (PQC, L7O), 2 pockets (best druggability 0.66). MolNFT v1 #76316 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
3QGY
Type
protein
Length
491 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase ITK/TSK
EC
2.7.10.2
UniProt
Q08881
Ligands
PQC, L7O
Pockets
2 · best druggability 0.66

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase ITK/TSK (EC 2.7.10.2)protein24640% helix, 18% strandQ08881
BTyrosine-protein kinase ITK/TSK (EC 2.7.10.2)protein24540% helix, 18% strandQ08881

Ligands and binding sites

  • PQC · 3-[(8-phenylthieno[2,3-h]quinazolin-2-yl)amino]benzenesulfonamide · ligand · chains A
  • L7O · N-{5-[2-(methylamino)pyrimidin-4-yl]-2-oxo-1,2-dihydropyridin-3-yl}-4-(piperidin-1-yl)benzamide · ligand · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13530.660.8034PQC
23740.650.7933L7O

Interfaces

1 interface between chains.

  • A–B · 59 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 3QGY · Crystal structure of ITK inhibitor complex · the same entry in another collection · chain A against A, TM-score 1.00
  • Q08881 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase ITK/TSK (Q08881) · a predicted model of the same protein · chain B against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.